Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Androgen effects on body composition.
Bhasin S, Woodhouse L, Storer TW. Bhasin S, et al. Growth Horm IGF Res. 2003 Aug;13 Suppl A:S63-71. doi: 10.1016/s1096-6374(03)00058-3. Growth Horm IGF Res. 2003. PMID: 12914730 Review.
Effects of an oral androgen on muscle and metabolism in older, community-dwelling men.
Schroeder ET, Singh A, Bhasin S, Storer TW, Azen C, Davidson T, Martinez C, Sinha-Hikim I, Jaque SV, Terk M, Sattler FR. Schroeder ET, et al. Among authors: bhasin s. Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E120-8. doi: 10.1152/ajpendo.00363.2002. Epub 2002 Sep 24. Am J Physiol Endocrinol Metab. 2003. PMID: 12388137 Free article. Clinical Trial.
Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men.
Jasuja R, Ramaraj P, Mac RP, Singh AB, Storer TW, Artaza J, Miller A, Singh R, Taylor WE, Lee ML, Davidson T, Sinha-Hikim I, Gonzalez-Cadavid N, Bhasin S. Jasuja R, et al. Among authors: bhasin s. J Clin Endocrinol Metab. 2005 Feb;90(2):855-63. doi: 10.1210/jc.2004-1577. Epub 2004 Nov 2. J Clin Endocrinol Metab. 2005. PMID: 15522925
A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S. Storer TW, et al. Among authors: bhasin s. J Clin Endocrinol Metab. 2005 Aug;90(8):4474-82. doi: 10.1210/jc.2005-0275. Epub 2005 May 24. J Clin Endocrinol Metab. 2005. PMID: 15914526 Clinical Trial.
738 results